The broad spectrum antiviral agent ribavirin inhibits capping of mRNA. 1979

B B Goswami, and E Borek, and O K Sharma, and J Fujitaki, and R A Smith

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D007739 L Cells A cultured line of C3H mouse FIBROBLASTS that do not adhere to one another and do not express CADHERINS. Earle's Strain L Cells,L Cell Line,L Cells (Cell Line),L-Cell Line,L-Cells,L-Cells, Cell Line,L929 Cell Line,L929 Cells,NCTC Clone 929 Cells,NCTC Clone 929 of Strain L Cells,Strain L Cells,Cell Line L-Cell,Cell Line L-Cells,Cell Line, L,Cell Line, L929,Cell Lines, L,Cell, L,Cell, L (Cell Line),Cell, L929,Cell, Strain L,Cells, L,Cells, L (Cell Line),Cells, L929,Cells, Strain L,L Cell,L Cell (Cell Line),L Cell Lines,L Cell, Strain,L Cells, Cell Line,L Cells, Strain,L-Cell,L-Cell Lines,L-Cell, Cell Line,L929 Cell,Strain L Cell
D009713 Nucleotidyltransferases A class of enzymes that transfers nucleotidyl residues. EC 2.7.7. Nucleotidyltransferase
D006157 Guanosine Monophosphate A guanine nucleotide containing one phosphate group esterified to the sugar moiety and found widely in nature. 5'-Guanylic Acid,Guanosine 5'-Monophosphate,5'-GMP,Guanylic Acid,5' Guanylic Acid,5'-Monophosphate, Guanosine,Acid, 5'-Guanylic,Acid, Guanylic,Guanosine 5' Monophosphate,Monophosphate, Guanosine
D006160 Guanosine Triphosphate Guanosine 5'-(tetrahydrogen triphosphate). A guanine nucleotide containing three phosphate groups esterified to the sugar moiety. GTP,Triphosphate, Guanosine
D012254 Ribavirin A nucleoside antimetabolite antiviral agent that blocks nucleic acid synthesis and is used against both RNA and DNA viruses. Ribovirin,Tribavirin,ICN-1229,Rebetol,Ribamide,Ribamidil,Ribamidyl,Ribasphere,Vilona,Viramide,Virazide,Virazole,ICN 1229,ICN1229
D012263 Ribonucleosides Nucleosides in which the purine or pyrimidine base is combined with ribose. (Dorland, 28th ed)
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D014542 Uridine Monophosphate 5'-Uridylic acid. A uracil nucleotide containing one phosphate group esterified to the sugar moiety in the 2', 3' or 5' position. UMP,Uridylic Acid,Uridine 5'-Monophosphate,Uridylic Acids,5'-Monophosphate, Uridine,Acid, Uridylic,Acids, Uridylic,Monophosphate, Uridine,Uridine 5' Monophosphate

Related Publications

B B Goswami, and E Borek, and O K Sharma, and J Fujitaki, and R A Smith
November 1983, Antimicrobial agents and chemotherapy,
B B Goswami, and E Borek, and O K Sharma, and J Fujitaki, and R A Smith
June 1987, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
B B Goswami, and E Borek, and O K Sharma, and J Fujitaki, and R A Smith
August 2001, Expert opinion on pharmacotherapy,
B B Goswami, and E Borek, and O K Sharma, and J Fujitaki, and R A Smith
May 2004, The Journal of biological chemistry,
B B Goswami, and E Borek, and O K Sharma, and J Fujitaki, and R A Smith
October 1984, Antimicrobial agents and chemotherapy,
B B Goswami, and E Borek, and O K Sharma, and J Fujitaki, and R A Smith
January 2007, Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic],
B B Goswami, and E Borek, and O K Sharma, and J Fujitaki, and R A Smith
December 2000, Nature medicine,
B B Goswami, and E Borek, and O K Sharma, and J Fujitaki, and R A Smith
May 2020, ACS infectious diseases,
B B Goswami, and E Borek, and O K Sharma, and J Fujitaki, and R A Smith
October 2014, Antiviral research,
B B Goswami, and E Borek, and O K Sharma, and J Fujitaki, and R A Smith
January 1979, Pharmacology & therapeutics,
Copied contents to your clipboard!